Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucophage SR in type 2 diabetes with chronic kidney disease
2011-004245-41Phase 2Terminated
- Sponsor
- Hywel Dda University Health Board
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) comparing Glucophage SR with Placebo (2 arms). Primary endpoint: Change in HbA1c from baseline to end of study. Started Aug 2012; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-004245-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004245-41.